Lupin releases generic Banzel
Generic Banzel is a prescription add-on medication approved for the treatment of seizures associated with Lennox-Gastaut syndrome.
Lupin is introducing rufinamide tablets, a generic of Eisai's Banzel.
Lupin's product is available in dosage strengths of 200 mg and 400 mg.
Generic Banzel is a prescription add-on medication approved for the treatment of seizures associated with Lennox-Gastaut syndrome in pediatric patients aged 1-year-old and older, as well as in adults.
[Read more: Lupin receives FDA OK for generic Banzel]
Rufinamide tablets had a market value of roughly $138 million, according to IQVIA October 2022 data.